// App-Quantinova.ai

TPS9642 : Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.

Researchers

Presenter

  • Annie Young

Principal Investigators

  • Jenny Phillips

  • Janet Dunn

  • Oliver Chapman

  • Helen Hancocks

  • Andrea Marshall

  • Joanne Grumett

Medical Centers

  • Warwick Clinical Trials Unit, Coventry, United Kingdom

  • Warwick Clinical Trials Unit, University of Warwick, Coventry, United KingdomThe University of Warwick, Coventry, EnglandUniversity of Warwick, Coventry, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • dalteparin Subcutaneous

Outcome

  • N/A

Study Design

  • open label

Phase

  • NA

Study Id's

  • ISRCTN86712308

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved